Due to their proliferative nature and being subject to oncogenic forces that either lead to heightened levels of reactive oxygen species or deregulated S-phase entry and/or progression, cancer cells are particularly vulnerable to ATR inhibition, experiencing extensive DNA and chromosomal damage. The gene discussed is ATR; the disease is cancer.